CNVM Secondary to Choroidal Rupture
PDT in Young Woman with Idiopathic CNVW
Sickle Cell Retinopathy
After acheiving initial gains visual gain or OCT improvement with a non-selective VEGF blocker, do you believe a different drug may be appropriate for safely maintaining those gains in the long term?
Yes
No
Give us your email address and we will notify you when our case studies are updated:
Case Study Archive
Keyword Search:
Sickle Cell Retinopathy
PDT in Young Woman with Idiopathic CNVW - 5 Year Follow Up
CNVM Secondary to Choroidal Rupture
Treatment of CNV in POHS with Bevacizumab
Avastin in a Boy with Sickle Cell - Induced CRVO
Intravitreal Moxifloxacin with Intravitreal Pegaptanib: Electroretinography and Clinical Results
Treatment of Retinal Angiomatous Proliferation
Treatment of a Chronic Occult Subfoveal Neovascular Membrane
Thyroid Carcinoma with Choroidal Metastasis
Sustained Vision Improvement followind Anti-VEGF Treatment
Management of Patient with Subretinal Hemorrhage
Presentations of Triple Therapy for Wet AMD
One Treatment with Photodynamic Therapy / Intravitreal Triamicinolone Aceonide (PDT/IVTA)
Peripapillary CNV with Submacular Hemorrhage
Anti-VEGF for CRVO
Extension of RPE Tear After Intravitreal Ranibizumab
Submacular Hemorrhage from Retinal Arterial Macroaneurysm
Intravitreal Bevacizumab (Avastin) for Wet AMD: 14-Month Course
Triple Therapy Using a Selective VEGF-Blockade Agent in the Setting of a Recent Cardiac Event
Spontaneous Subretinal Hemorrhage from Presumed Eccentric Disciform
CRVO with Macular Edema Repeatedly Treated with Bevacizumab (Avastin) Over One Year Period
Rapid Onset of Tractional Retinal Detachment Following Intravitreal Injection of Bevacizumab (Avastin) in a Patient with Severe Diabetic Retinopathy
Myocardial Infarction after Avastin
Choroidal Infarction after PDT
Macugen Injection after PDT and IVK
CNVM Due to Angioid Streaks
Induction/Maintenance 1 Year Follow-Up
Monocular Patient with Submacular Hemorrhage: A Case for Induction/Maintenance?
Significant Visual Acuity Improvement Following Treatment of Early Subfoveal Occult Choroidal Neovascular Membrane with Macugen
Macugen® for Early Recurrence of CNV Following Successful Induction with PDT + Intravitreal Triamcinolone
Reduced Fluence PDT + Macugen®
Macugen® Experience at The Eye Institute of West Florida